Getein Biotech Inc Financial Flexibility Index
Getein Biotech Inc financial flexibility index. Getein Biotech Inc (603387) has a Financial Flexibility Index of 0.13x as of September 2025. Free cash flow of CN¥135.23 Million (operating CF CN¥100.90 Million minus capex CN¥34.34 Million) represents 0% of total liabilities (CN¥1.04 Billion). See Getein Biotech Inc (603387) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Getein Biotech Inc (2012–2025)
Financial flexibility index of Getein Biotech Inc from 2012 to 2025. Historical Financial Flexibility Index trend for Getein Biotech Inc across 14 annual periods. Check Getein Biotech Inc (603387) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Getein Biotech Inc Financial Flexibility Index by Year (2012–2025)
Getein Biotech Inc financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Getein Biotech Inc. For the full cash flow conversion analysis, see Getein Biotech Inc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | CN¥543.17 Million | CN¥392.59 Million | CN¥896.55 Million | ▲ +3.1% |
| 2024 | 0.59x | CN¥579.40 Million | CN¥423.00 Million | CN¥986.42 Million | ▲ +2.3% |
| 2023 | 0.57x | CN¥591.35 Million | CN¥333.22 Million | CN¥1.03 Billion | ▼ -17.0% |
| 2022 | 0.69x | CN¥700.40 Million | CN¥482.96 Million | CN¥1.01 Billion | ▼ -2.4% |
| 2021 | 0.71x | CN¥611.96 Million | CN¥432.36 Million | CN¥863.90 Million | ▲ +64.9% |
| 2020 | 0.43x | CN¥299.00 Million | CN¥185.47 Million | CN¥695.95 Million | ▼ -60.0% |
| 2019 | 1.08x | CN¥350.55 Million | CN¥225.73 Million | CN¥325.98 Million | ▼ -32.4% |
| 2018 | 1.59x | CN¥297.84 Million | CN¥187.10 Million | CN¥187.23 Million | ▼ -25.3% |
| 2017 | 2.13x | CN¥253.26 Million | CN¥191.91 Million | CN¥118.87 Million | ▼ -0.6% |
| 2016 | 2.14x | CN¥195.23 Million | CN¥155.91 Million | CN¥91.13 Million | ▼ -24.3% |
| 2015 | 2.83x | CN¥168.38 Million | CN¥121.73 Million | CN¥59.48 Million | ▼ -30.7% |
| 2014 | 4.09x | CN¥168.62 Million | CN¥98.53 Million | CN¥41.26 Million | ▲ +301.2% |
| 2013 | 1.02x | CN¥71.74 Million | CN¥59.72 Million | CN¥70.42 Million | ▲ +46.5% |
| 2012 | 0.70x | CN¥34.19 Million | CN¥23.80 Million | CN¥49.15 Million | — |